We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 04 Feb 2025

Sysmex (Kobe, Japan) is participating at Medlab Middle East 2025 as a platinum sponsor where the company is showcasing its latest laboratory innovations and technologies and also hosting workshops. More...

At the 2025 edition of Medlab Middle East, Sysmex is highlighting BloodScience Workcell, its novel laboratory automation concept which smartly combines hematology and hemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. BloodScience Workcell consolidates the workflow automation of EDTA and citrate blood sample tubes by combining hematology automation lines, XR-9000 or XN-9100, with the new CN track for hemostasis. Also featured is the UN-Series of urinalysis solutions which can automate a lab’s urinalysis work area according to required workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit and a secure investment.

Sysmex is also showcasing its comprehensive line of IVD flow cytometry products, headlined by the advanced PS-10 sample preparation system and the XF-1600 flow cytometer, in addition to an extensive portfolio of monoclonal antibodies and consumables. Sysmex is demonstrating CyFlow WA, its innovative Work Area Manager (WAM) software, which is the key to a smartly connected modern clinical flow cytometry lab. It integrates seamlessly with existing Sysmex lab equipment, acting as a powerful middleware solution bridging hematology and clinical flow cytometry data analysis.

Among its other solutions, Sysmex is showcasing HISCL-800, the latest addition to its HISCL family of automated immunoassay systems. The unique features of HISCL-800 include fast reaction time with throughput of up to 100 tests per hour, delivering highly sensitive and specific clinical results with small footprint, making it an ideal partner for small and medium-sized laboratories. With a fast reaction time for every parameter, it takes 17 mins to get the first test result. The HISCL-800’s rapid analysis enables laboratories to meet their reporting objectives, especially for STAT samples. Visitors to the Sysmex booth can also view digital displays of its cancer diagnostic solutions for breast cancer and colorectal cancer.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
PBC Assay
Primary Biliary Cholangitis Assays
New
Silver Member
Cell and Tissue Culture Plastics
Diamond® SureGro™ Cell and Tissue Culture Plastics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.